Web Results

Wolfe v. North Carolina

en.wikipedia.org/wiki/Wolfe_v._North_Carolina

Wolfe v. North Carolina 364 U.S. 177 (1960), is a 1960 United States Supreme Court case in ... Wolfe et al v. North Carolina. Seal of the United States Supreme Court.svg. Supreme Court of the United...

Thalidomide in induction treatment increases the very good partial ...

www.ncbi.nlm.nih.gov/pubmed/18166796

Lokhorst HM(1), Schmidt-Wolf I, Sonneveld P, van der Holt B, Martin H, Barge R ... patients randomized to VAD (vincristine, adriamycin, dexamethasone, 72% vs.

A randomized phase 3 study on the effect of thalidomide combined ...

www.bloodjournal.org/content/115/6/1113

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, ..... Patients randomized to thalidomide had a significantly prolonged EFScens (34 months vs 22 months; HR = 0.60 ..... Lokhorst HM,; Schmidt-Wolf I,; Sonneveld P,; et al.

Achievement of at Least Very Good Partial Response Is a Simple ...

jco.ascopubs.org/content/27/34/5720.full

HM Lokhorst, I Schmidt-Wolf, P Sonneveld , etal : Thalidomide in induction ... M Pineda-Roman, V Bolejack, V Arzoumanian , etal : Complete response in ...

Full Article (WORD) - World Journal of Gastroenterology

www.wjgnet.com/esps/DownLoadFile.aspx?Type=Digital&SubType=2&DOI=10.5500/wjt.v6.i2.321&FilePath=Pub\10.5500\v6\i2\WJT-6-321.doc

Mar 22, 2016 ... First line vs delayed transplantation in myeloma: Certainties and controversies .... From 1990 to 1995, Fermand et al randomly assigned 185 patients to receive early ..... 33 Lokhorst HM, van der Holt B, Zweegman S, Vellenga E, ... 34 Sonneveld P, Schmidt-Wolf IG, van der Holt B, El Jarari L, Bertsch U, ...

Vincristine, doxorubicin and dexamethasone (VAD) administered as ...

onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.1999.01279.x/full

H. M. Lokhorst ... myeloma which did not show superiority over melphalan and prednisolone (Gregory et al, 1992). .... treated with continuous infusion of VAD ( 22% v 100%) (Alexanian et al, 1990; Samson et al, 1989). .... Z. Brouwers-Vos, Jan Jacob Schuringa, Edo Vellenga, Joost T.M. de Wolf, Gerwin Huls, Aging Impairs ...

Comment on “Outcomes of autologous transplantation for multiple ...

www.sciencedirect.com/science/article/pii/S1516848414500278

Jul 8, 2014 ... H.M. Lokhorst, I. Schmidt-Wolf, P. Sonneveld, B. van der Holt, H. Martin, R. Barge, ... M. Macro, M. Divine, Y. Uzunhan, A. Jaccard, D. Bouscary, V. Leblond, et al. ... See paper by Crusoe EQ et al, on Rev Bras Hematol Hemoter.

to view Article - International Myeloma Foundation

www.myeloma.org/sites/default/files/images/research/blood-2012-ludwig.pdf

Jan 23, 2012 ... packages METASUB V. 1.1 (idv, Gauting, Germany) and Review Manager V. 4.2 ...... Lokhorst HM, Schmidt-Wolf I, Sonneveld P, et al.

Advances in the Autologous and Allogeneic Transplantation ...

moffitt.org/File Library/Main Nav/Research and Clinical Trials/Cancer Control Journal/v18n4/258.pdf

Oct 2, 2011 ... Due in part to a potential graft-vs-myeloma effect, allogeneic HCT is a potentially curative ...... Lokhorst HM, Schmidt-Wolf I, Sonneveld P, et al.

new developments in the treatment of patients with multiple myeloma

www.njmonline.nl/getpdf.php?id=875

(ns). Lokhorst et al. 20098. VAD vs TAD. 79 vs 88%. 25 vs 34. 60 vs 73 (ns). T 200 mg ... thalidomide had a median OS after relapse of 20 months vs. 31 months  ...

More Info

Wolfe v. Grange Indemn. Ins. Co. :: 2012 :: Ohio Court of Appeals ...

law.justia.com

Wolfe v. Grange Indemn. Ins. Co. - 2012-Ohio-598. ... Wolfe v. Grange Indemn. Ins. Co. Annotate this Case · Download PDF. Select print range ...

Wolfe v. Rodriguez et al (0:16-cv-62797), Florida Southern District ...

www.pacermonitor.com

6 days ago ... Wolfe v. Rodriguez et al (0:16-cv-62797), Florida Southern District Court, Filed: 11/28/2016 - PacerMonitor Mobile Federal and Bankruptcy ...

Leukemia - Monoclonal antibodies in the treatment of multiple ...

www.nature.com

Oct 9, 2015 ... Median PFS was also longer in the high-dose cohort (23 vs 14.9 ...... Plesner T, Arkenau HT, Lokhorst HM, Gimsing P, Krejcik J, Lemech C et al. ..... Chanan- Khan A, Wolf JL, Garcia J, Gharibo M, Jagannath S, Manfredi D et al.